NFKB1 and myositis disease: We find that 1) expression of DTMs is increased by inflammatory NF-κB signaling, 2) these DTMs are upregulated in muscle diseases such as BMD, DMD, and myositis, and 3) vamorolone reduces expression of DTMs in mdx mice.14